Clinical Trials Directory

Trials / Completed

CompletedNCT02814487

MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.

A Pilot Validation Study Comparing "DAM" a Smartphone Application With the Composite MSFC Score Intra-individually Among Multiple Sclerosis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Ad scientiam · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multiple Sclerosis Functional Composite score (MSFC) is one of the gold standard for multiple sclerosis (MS) patient clinical evaluation. However, its practical implementation is not always optimal as it can prove to be very time consuming. Moreover, it often constrains the range of tests used and is not a particularly good marker for patient real life disability status. A mobile application called Digital Self-Assessment for Multiple Sclerosis (DAM) was developed in order to replicate each of MSFC tests available in order to assess MS progression in the patient environment.

Detailed description

Patients are selected during a consultation at the Neurology department of the Pitié-Salpêtrière Hospital (France). Each patient is given access to DAM on their own or a provided iPhone. During the enrolment visit, patients have to complete a MSFC and DAM evaluation (V0). Through a push-notification on their phone, patients are reminded to perform two DAM evaluations at home at days 30 (V1) and 60 (V2). At day 90 (V3), they have to come back to hospital for a second MSFC and DAM evaluation

Conditions

Timeline

Start date
2015-12-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-06-27
Last updated
2016-09-12

Source: ClinicalTrials.gov record NCT02814487. Inclusion in this directory is not an endorsement.